Skip to content

Endometrial Curettage Before Embryo Transfer

Endometrial Hysteroscopy and Curettage Prior to Embryo Transfer

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00367367
Enrollment
90
Registered
2006-08-22
Start date
2005-12-31
Completion date
Unknown
Last updated
2006-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

embryo transfer, hysteroscopy, curettage, iv-vitro fertilization, molecular markers, endometrial receptivity, endometrial dating

Brief summary

Studies have shown that endometrial sampling in the month prior to embryo transfer may increase pregnancy rates. We wish to test this hypothesis by performing a hysteroscopy and curettage in the month proceeding embryo transfer during IVF, IVF/ICSI or Frozen/Thawed cycles.

Detailed description

It has been suggested that local injury to the endometrium doubles the rate of implantation and successful pregnancies in IVF patients. Purpose 1. To determine whether performing curettage the month prior to embryo transfer (ET) increases the chance of embryo implantation. 2. To study molecular attributes of the endometrium taken at curettage and to compare them to those cycles resulting in pregnancy and those which do not result in pregnancy. Samples will be grown as primary culture in the research laboratory and possible molecular markers and attachment assays for endometrial receptivity will be studied. Patient selection: Patients undergoing IVF or IVF-ICSI at Ha'Emek medical center/ IVF unit. Woman over 35 years of age will be excluded since implantation failure is more likely to be due to genetic, chromosomal or cytoplasmic aberrations in their oocytes. Proposed protocol: 1. Informed consent obtained from prospective candidates. 2. Participants randomly divided to three groups 1. Control group 2. Hysteroscopy and curettage performed on days 15-17 of menstrual cycle 3. Hysteroscopy and curettage performed on days 19-22 of menstrual cycle 3. After the following menses an IVF, IVF-ICSI, or frozen embryo cycle is performed according to the unit's standard protocols. 4. The primary end point of the study will be the implantation rate after ET and the expression of possible molecular markers for endometrial receptivity in the pregnant patients.

Interventions

PROCEDUREHysteroscopy and Curettage

Sponsors

Technion, Israel Institute of Technology
CollaboratorOTHER
HaEmek Medical Center, Israel
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Informed consent * In-vitro fertilization candidate * Normal blood coagulation

Exclusion criteria

* Anemia (hemoglobin under 10 mg/dl) * Abnormal maternal karyotype * Thrombocytopenia under 140,000 * Any contraindication to hysteroscopy or in-vitro fertilization

Design outcomes

Primary

MeasureTime frame
Implantation rate
Pregnancy rate
Endometrial receptivity

Countries

Israel

Contacts

Primary ContactAmir Weiss, MD
weiss_am@clalit.org.il972-4-6494031
Backup ContactJoel Geslevich, MD
yoel_g@clalit.org.il972-4-6495488

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026